Weizmann institute develops groundbreaking prostate cancer treatment
Professor Avigdor Scherz and Professor Yoram Salomon of the Weizmann Institute develop treatment for prostate cancer patients that targets tumor without damaging healthy tissue.
The incidence of prostate cancer, especially among men, in Israel has increased in the past two decades. However, Professor Avigdor Scherz and Professor Yoram Salomon of the Weizmann Institute have developed a groundbreaking treatment, bearing good news for the patients diagnosed with the deadly disease.
Prostate cancer patients face a dilemma today: Undergoing prostate surgery and radiation, which often causes erectile dysfunction and urinary retention, or staying under “active surveillance,” which could allow the cancer to metastasize. Most prostate cancer patients choose the latter.
However, the two professors’ treatment does not require cancer patients to choose either. In fact, it narrowly targets tumors on the prostate without damaging genitalia, urinary tract, or general quality of life.
The treatment is injected intravenously for 10 minutes and does not harm the healthy tissue surrounding the tumor. Immediately after the injection, the malignant tissue is exposed to light for 22 minutes via tiny optical fibers.
Shining a light on the tumor causes a chain reaction, destroying tumor without damaging
FOR ENTIRE ARTICLE CLICK LINKClick here for the Top 12 Moments in Jewish History...LET THE ADVENTURE BEGIN! »